Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
Starting soon · Not applicable
Conditions studied: Referral and Consultation, Glomerulonephritis, Hematuria, Proteinuria, Kidney Disease
In brief
The purpose of the study is to evaluate prospectively the impact of an electronic health record (EHR) alert on primary care providers' (PCP) referral to Nephrology of Geisinger patients with high risk signs (blood and protein in the urine) of glomerulonephritis. This will help quantify the relative effectiveness of EHR alerts on PCPs' referral patterns.
Key facts
- Study ID
- NCT07431931
- Run by
- Geisinger Clinic
- People needed
- 1200
- Starts
- 2026-11-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-05-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged ≥18 years
- Patients receiving care from any Geisinger primary care provider (record of an encounter with a Geisinger PCP within the last 2 years from date of survey implementation)
- Patients with high-risk glomerulonephritis features i.e. positive test results for hematuria (urine dipstick result with blood 1+ or greater) and proteinuria (2+ or 3+ protein on dipstick or ACR≥300 mg/g or PCR ≥500 mg/g) collected within 12 months of index date.
You may not qualify if…
- Patients with a nephrologist appointment in the last 12 months before the index date
- Patients with a prior appointment with a nephrologist within the last 2 years before the positive urinalysis test for hematuria (1+ or greater)
- Patients with a history of glomerulonephritis and/or kidney failure (dialysis or eGFR < 15 mL/min/1.73m2, or kidney transplantation) at any time during the baseline
- Patients receiving palliative care at any time during the baseline
Where it is running
- Geisinger Medical Center — Danville, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.